tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Aptose’s TUSCANY Trial Data to be Presented at EHA 2025
Company AnnouncementsAptose’s TUSCANY Trial Data to be Presented at EHA 2025
1d ago
Aptose Biosciences Reports Q1 2025 Financial Results
PremiumCompany Announcements
Aptose Biosciences Reports Q1 2025 Financial Results
2d ago
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
PremiumCompany Announcements
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
7d ago
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
PremiumCompany Announcements
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
10d ago
Aptose Biosciences Auditor KPMG Not Re-Appointed
PremiumCompany Announcements
Aptose Biosciences Auditor KPMG Not Re-Appointed
22d ago
8K
Aptose Biosciences Advances AML Therapy with Promising Results
PremiumCompany AnnouncementsAptose Biosciences Advances AML Therapy with Promising Results
1M ago
Aptose Biosciences to Delist from Nasdaq in April
Premium
Company Announcements
Aptose Biosciences to Delist from Nasdaq in April
1M ago
8K
APTO
Aptose Biosciences shares to delist from Nasdaq as of April 2
Premium
The Fly
Aptose Biosciences shares to delist from Nasdaq as of April 2
1M ago
APTO
Aptose Biosciences: Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
PremiumRatings
Aptose Biosciences: Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
2M ago
APTO
Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
PremiumThe Fly
Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
2M ago
APTO
Aptose Biosciences Advances AML Therapy and Strengthens Financial Position
PremiumCompany Announcements
Aptose Biosciences Advances AML Therapy and Strengthens Financial Position
2M ago
APTO
Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year
PremiumThe Fly
Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year
2M ago
APTO
Aptose Biosciences (APTO) Q4 Earnings Cheat Sheet
PremiumPre-EarningsAptose Biosciences (APTO) Q4 Earnings Cheat Sheet
2M ago
APTO
Aptose Biosciences Regains Nasdaq Bid Price Compliance
Premium
Company Announcements
Aptose Biosciences Regains Nasdaq Bid Price Compliance
2M ago
8K
APTO
Aptose Biosciences meets Nasdaq minimum bid price compliance
Premium
The Fly
Aptose Biosciences meets Nasdaq minimum bid price compliance
2M ago
APTO
Aptose Biosciences initiated with a Speculative Buy at Alliance Global Partners
PremiumThe Fly
Aptose Biosciences initiated with a Speculative Buy at Alliance Global Partners
3M ago
APTO
Aptose Biosciences trading halted, news pending
PremiumThe Fly
Aptose Biosciences trading halted, news pending
3M ago
APTO
Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
PremiumCompany Announcements
Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
3M ago
8K
APTO
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
PremiumThe Fly
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
3M ago
APTO
Aptose Biosciences Announces Reverse Share Split
PremiumCompany AnnouncementsAptose Biosciences Announces Reverse Share Split
3M ago
8K
APTO
Aptose Biosciences announces 1-for-30 reverse share split
Premium
The Fly
Aptose Biosciences announces 1-for-30 reverse share split
3M ago
APTO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
XLO
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >